2025 Q3 -tulosraportti
68 päivää sitten23 min
4,00 SEK/osake
Viimeisin osinko
2,72%Tuotto/v
Tarjoustasot
First North Sweden
Määrä
Osto
2 029
Myynti
Määrä
2 532
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 | - | - | ||
| 89 | - | - | ||
| 3 | - | - | ||
| 96 | - | - | ||
| 15 | - | - |
Ylin
148,2VWAP
Alin
143,6VaihtoMäärä
5,6 38 099
VWAP
Ylin
148,2Alin
143,6VaihtoMäärä
5,6 38 099
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 25.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 20.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 19.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·19.1.Zinzino and possible Trump tariff: Lower risk than many believe Recently, there has been some speculation about possible increased tariffs from the USA in connection with the Trump case concerning Greenland, where Norway is mentioned on the list of countries that could be affected. I nevertheless believe that Zinzino (ZZ B) is less exposed to this than many initially assume. 1) Significantly more production in the USA after acquisitions in 2025 In 2025, Zinzino acquired three companies in the USA (Zurvita, Bodē Pro and Truvy), and these have their products produced in the USA. In my assessment, this is an important point, because it reduces exposure to import tariffs directly into the American market. 2) Only a small part of the products in the USA are produced in Norway As far as I understand, only a few percent of Zinzino's American product range is produced in Norway. This includes Xtend and ZinoBiotic+. Should it become necessary, it also does not seem particularly complicated to move this production to the USA to further reduce tariff impact. 3) The main product BalanceOil is produced in Iceland Zinzino's most important product, BalanceOil+, is produced in Iceland. Iceland is not on the list of countries covered by this current tariff case, as I understand it. This means that the core product in the portfolio is potentially well shielded against exactly this type of risk. 4) Pricing can be adjusted in the American market Even if tariffs were to hit hard on certain products, there is also commercial leeway: prices can be adjusted in the American market. This is, of course, never ideal, but it gives the company an opportunity to protect margins if the framework conditions change. Conclusion My assessment is that Zinzino stands relatively robust in the face of these types of tariff scenarios, especially because much of the USA-oriented portfolio is already produced in the USA, and because BalanceOil is produced in Iceland. The risk is not zero, but the exposure seems, in my view, more manageable than the headlines might suggest. Disclaimer I am a partner and shareholder in Zinzino. My statements are based on my own thoughts and assessments, and should not be perceived as investment advice. Always do your own analyses before making investment decisions.
·21.1.Well, one can certainly hope that a mature politician comes to the helm in the USA so we can get a normal financial world etc.🙏
·12.1.What's happening with Zinzino? 🥲·16.1.Zinzino shares are what I have invested in, looking for a stock that will rise to a price of 800/1000 in 2030 / 2035, so my advice would be “be positive and patient”
·8.1.Does anyone know why no analysts follow the company? Revenue is starting to get some size now..
·8.1.I am very curious about Zinzino's development in 2026 and see several factors that can contribute to continued momentum: • Full year effect from acquisitions completed in 2025. • Integration of new networks and how quickly they become active on ZZs products and systems. • The effect of recruitment in H2 2025, which may only fully materialize in 2026. • Pipeline of new partners and teams that are under construction, but not yet fully productive. • Contribution from newer products that have only been on the market for a short time, including repurchase and subscription behavior. • Development in new markets, where volume often starts low, but can accelerate. • Potential synergies from acquisitions, e.g. cross-selling and increased activity in existing networks. • Seasonal patterns in health & wellness, especially the start of the year. • Operational scaling and earnings. It will be exciting to see how these factors collectively can contribute to growth and momentum being maintained – or hopefully increasing over time. Please share your thoughts on the above and especially if you have insights or knowledge of one, several or other factors that can contribute in 2026 and beyond?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
68 päivää sitten23 min
4,00 SEK/osake
Viimeisin osinko
2,72%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·19.1.Zinzino and possible Trump tariff: Lower risk than many believe Recently, there has been some speculation about possible increased tariffs from the USA in connection with the Trump case concerning Greenland, where Norway is mentioned on the list of countries that could be affected. I nevertheless believe that Zinzino (ZZ B) is less exposed to this than many initially assume. 1) Significantly more production in the USA after acquisitions in 2025 In 2025, Zinzino acquired three companies in the USA (Zurvita, Bodē Pro and Truvy), and these have their products produced in the USA. In my assessment, this is an important point, because it reduces exposure to import tariffs directly into the American market. 2) Only a small part of the products in the USA are produced in Norway As far as I understand, only a few percent of Zinzino's American product range is produced in Norway. This includes Xtend and ZinoBiotic+. Should it become necessary, it also does not seem particularly complicated to move this production to the USA to further reduce tariff impact. 3) The main product BalanceOil is produced in Iceland Zinzino's most important product, BalanceOil+, is produced in Iceland. Iceland is not on the list of countries covered by this current tariff case, as I understand it. This means that the core product in the portfolio is potentially well shielded against exactly this type of risk. 4) Pricing can be adjusted in the American market Even if tariffs were to hit hard on certain products, there is also commercial leeway: prices can be adjusted in the American market. This is, of course, never ideal, but it gives the company an opportunity to protect margins if the framework conditions change. Conclusion My assessment is that Zinzino stands relatively robust in the face of these types of tariff scenarios, especially because much of the USA-oriented portfolio is already produced in the USA, and because BalanceOil is produced in Iceland. The risk is not zero, but the exposure seems, in my view, more manageable than the headlines might suggest. Disclaimer I am a partner and shareholder in Zinzino. My statements are based on my own thoughts and assessments, and should not be perceived as investment advice. Always do your own analyses before making investment decisions.·21.1.Well, one can certainly hope that a mature politician comes to the helm in the USA so we can get a normal financial world etc.🙏
- ·12.1.What's happening with Zinzino? 🥲·16.1.Zinzino shares are what I have invested in, looking for a stock that will rise to a price of 800/1000 in 2030 / 2035, so my advice would be “be positive and patient”
- ·8.1.Does anyone know why no analysts follow the company? Revenue is starting to get some size now..
- ·8.1.I am very curious about Zinzino's development in 2026 and see several factors that can contribute to continued momentum: • Full year effect from acquisitions completed in 2025. • Integration of new networks and how quickly they become active on ZZs products and systems. • The effect of recruitment in H2 2025, which may only fully materialize in 2026. • Pipeline of new partners and teams that are under construction, but not yet fully productive. • Contribution from newer products that have only been on the market for a short time, including repurchase and subscription behavior. • Development in new markets, where volume often starts low, but can accelerate. • Potential synergies from acquisitions, e.g. cross-selling and increased activity in existing networks. • Seasonal patterns in health & wellness, especially the start of the year. • Operational scaling and earnings. It will be exciting to see how these factors collectively can contribute to growth and momentum being maintained – or hopefully increasing over time. Please share your thoughts on the above and especially if you have insights or knowledge of one, several or other factors that can contribute in 2026 and beyond?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
2 029
Myynti
Määrä
2 532
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 | - | - | ||
| 89 | - | - | ||
| 3 | - | - | ||
| 96 | - | - | ||
| 15 | - | - |
Ylin
148,2VWAP
Alin
143,6VaihtoMäärä
5,6 38 099
VWAP
Ylin
148,2Alin
143,6VaihtoMäärä
5,6 38 099
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 25.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 20.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 19.11.2024 |
2025 Q3 -tulosraportti
68 päivää sitten23 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 25.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 20.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 19.11.2024 |
4,00 SEK/osake
Viimeisin osinko
2,72%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·19.1.Zinzino and possible Trump tariff: Lower risk than many believe Recently, there has been some speculation about possible increased tariffs from the USA in connection with the Trump case concerning Greenland, where Norway is mentioned on the list of countries that could be affected. I nevertheless believe that Zinzino (ZZ B) is less exposed to this than many initially assume. 1) Significantly more production in the USA after acquisitions in 2025 In 2025, Zinzino acquired three companies in the USA (Zurvita, Bodē Pro and Truvy), and these have their products produced in the USA. In my assessment, this is an important point, because it reduces exposure to import tariffs directly into the American market. 2) Only a small part of the products in the USA are produced in Norway As far as I understand, only a few percent of Zinzino's American product range is produced in Norway. This includes Xtend and ZinoBiotic+. Should it become necessary, it also does not seem particularly complicated to move this production to the USA to further reduce tariff impact. 3) The main product BalanceOil is produced in Iceland Zinzino's most important product, BalanceOil+, is produced in Iceland. Iceland is not on the list of countries covered by this current tariff case, as I understand it. This means that the core product in the portfolio is potentially well shielded against exactly this type of risk. 4) Pricing can be adjusted in the American market Even if tariffs were to hit hard on certain products, there is also commercial leeway: prices can be adjusted in the American market. This is, of course, never ideal, but it gives the company an opportunity to protect margins if the framework conditions change. Conclusion My assessment is that Zinzino stands relatively robust in the face of these types of tariff scenarios, especially because much of the USA-oriented portfolio is already produced in the USA, and because BalanceOil is produced in Iceland. The risk is not zero, but the exposure seems, in my view, more manageable than the headlines might suggest. Disclaimer I am a partner and shareholder in Zinzino. My statements are based on my own thoughts and assessments, and should not be perceived as investment advice. Always do your own analyses before making investment decisions.·21.1.Well, one can certainly hope that a mature politician comes to the helm in the USA so we can get a normal financial world etc.🙏
- ·12.1.What's happening with Zinzino? 🥲·16.1.Zinzino shares are what I have invested in, looking for a stock that will rise to a price of 800/1000 in 2030 / 2035, so my advice would be “be positive and patient”
- ·8.1.Does anyone know why no analysts follow the company? Revenue is starting to get some size now..
- ·8.1.I am very curious about Zinzino's development in 2026 and see several factors that can contribute to continued momentum: • Full year effect from acquisitions completed in 2025. • Integration of new networks and how quickly they become active on ZZs products and systems. • The effect of recruitment in H2 2025, which may only fully materialize in 2026. • Pipeline of new partners and teams that are under construction, but not yet fully productive. • Contribution from newer products that have only been on the market for a short time, including repurchase and subscription behavior. • Development in new markets, where volume often starts low, but can accelerate. • Potential synergies from acquisitions, e.g. cross-selling and increased activity in existing networks. • Seasonal patterns in health & wellness, especially the start of the year. • Operational scaling and earnings. It will be exciting to see how these factors collectively can contribute to growth and momentum being maintained – or hopefully increasing over time. Please share your thoughts on the above and especially if you have insights or knowledge of one, several or other factors that can contribute in 2026 and beyond?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
2 029
Myynti
Määrä
2 532
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 | - | - | ||
| 89 | - | - | ||
| 3 | - | - | ||
| 96 | - | - | ||
| 15 | - | - |
Ylin
148,2VWAP
Alin
143,6VaihtoMäärä
5,6 38 099
VWAP
Ylin
148,2Alin
143,6VaihtoMäärä
5,6 38 099
Välittäjätilasto
Dataa ei löytynyt